Correlation Between Puma Biotechnology and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Puma Biotechnology and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Quoin Pharmaceuticals.
Diversification Opportunities for Puma Biotechnology and Quoin Pharmaceuticals
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Puma and Quoin is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Quoin Pharmaceuticals
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 5.75 times less return on investment than Quoin Pharmaceuticals. But when comparing it to its historical volatility, Puma Biotechnology is 2.32 times less risky than Quoin Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 51.00 in Quoin Pharmaceuticals Ltd on September 13, 2024 and sell it today you would earn a total of 26.00 from holding Quoin Pharmaceuticals Ltd or generate 50.98% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Puma Biotechnology vs. Quoin Pharmaceuticals Ltd
Performance |
Timeline |
Puma Biotechnology |
Quoin Pharmaceuticals |
Puma Biotechnology and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Puma Biotechnology and Quoin Pharmaceuticals
The main advantage of trading using opposite Puma Biotechnology and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Quoin Pharmaceuticals vs. Puma Biotechnology | Quoin Pharmaceuticals vs. Iovance Biotherapeutics | Quoin Pharmaceuticals vs. Sarepta Therapeutics | Quoin Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Equity Valuation Check real value of public entities based on technical and fundamental data |